1. Home
  2. BESS vs IRIX Comparison

BESS vs IRIX Comparison

Compare BESS & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BESS

Bimergen Energy Corporation Common Stock

N/A

Current Price

$4.13

Market Cap

16.6M

Sector

N/A

ML Signal

N/A

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$1.04

Market Cap

18.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BESS
IRIX
Founded
1998
1989
Country
United States
United States
Employees
3
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.6M
18.2M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
BESS
IRIX
Price
$4.13
$1.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
239.5K
50.0K
Earning Date
03-31-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.85
EPS
N/A
N/A
Revenue
N/A
$41,593,000.00
Revenue This Year
N/A
$3.07
Revenue Next Year
N/A
$6.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$0.87
52 Week High
$5.00
$1.65

Technical Indicators

Market Signals
Indicator
BESS
IRIX
Relative Strength Index (RSI) 63.96 47.95
Support Level $2.03 $1.01
Resistance Level N/A $1.18
Average True Range (ATR) 0.59 0.03
MACD 0.13 0.01
Stochastic Oscillator 70.71 61.11

Price Performance

Historical Comparison
BESS
IRIX

About BESS Bimergen Energy Corporation Common Stock

Bimergen Energy Corp is a renewable energy project developer that enables the clean energy transition and provides critical grid stability via solutions across a range of applications through portfolio of utility-scale Battery Energy Storage System (BESS) and solar development projects. Its portfolio includes approximately 23 development-stage utility-scale BESS projects with a projected total storage capacity of around 1.965 gigawatts (GW) and approximately 13 development-stage solar energy projects expected to generate around 1.640 GW upon completion and operation.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: